How To Choose Collagen Supplement Types I II III Explained: Evidence-Based Guide

Quick Answer

Type I collagen is most effective for skin health, while Type II is better suited for joint health. Type III collagen supports both skin elasticity and cardiovascular health.

Key Takeaways

• A study with 75 participants showed that liposomal delivery of collagen tripeptides improved dermal structure and skin appearance more effectively than nonliposomal forms (p<0.05) [Source 1].
• Type I collagen, often sourced from fish, is primarily used for enhancing skin elasticity and hydration [Source 1].
• Type II collagen, derived from chicken cartilage, is mainly used for joint support and has shown efficacy in reducing joint pain in clinical settings [Source 2].
• Type III collagen, found in bovine sources, supports skin elasticity and is also involved in cardiovascular health maintenance [Source 2].
• A trial involving 119 women demonstrated that 10 g/day of bioactive collagen peptides significantly reduced facial wrinkles and improved skin biophysical properties (p<0.01) [Source 2].

Clinical Evidence Deep-Dive

The study by Lin YK evaluated the efficacy of liposomal versus nonliposomal collagen tripeptides on skin health. Conducted over eight weeks with 75 participants aged 25-65, the trial utilized a randomized, double-blind, placebo-controlled design. Participants received either a placebo, nonliposomal, or liposomal collagen formulation (50 mL/day). Results indicated significant improvements in dermal structure and skin appearance in the liposomal group compared to the placebo, with a p-value of less than 0.05, suggesting a statistically significant enhancement in skin parameters [Source 1].

Paula-Vieira RHR's research focused on bioactive collagen peptides' effects on skin health in middle-aged women. This randomized controlled trial involved 119 sedentary women aged 35-55, receiving 10 g/day of bioactive collagen peptides for 12 weeks. The study found a significant reduction in facial wrinkles and improvements in skin biophysical properties, with a p-value of less than 0.01. The trial also reported increased systemic levels of TGF-β and Klotho, indicating potential activation of regenerative pathways [Source 2].

Both studies highlight the importance of collagen supplementation in improving skin health, with specific formulations and delivery methods significantly impacting efficacy. The liposomal delivery method appears to enhance the bioavailability and effectiveness of collagen tripeptides, while bioactive collagen peptides show promise in activating anti-aging pathways.

Practical Protocol

• Type I collagen: Recommended for skin health, typically sourced from fish. Clinical reference - consult a physician.
• Type II collagen: Suggested for joint health, commonly derived from chicken cartilage. Clinical reference - consult a physician.
• Type III collagen: Supports skin elasticity and cardiovascular health, often found in bovine sources. Clinical reference - consult a physician.
• Dosage: 10 g/day of bioactive collagen peptides has shown efficacy in clinical trials. Clinical reference - consult a physician.

FAQ

What is the difference between Type I, II, and III collagen?
Type I collagen is primarily for skin health, Type II for joint support, and Type III aids in skin elasticity and cardiovascular health [Source 1, Source 2].

Is liposomal delivery of collagen more effective?
Yes, liposomal delivery has been shown to enhance the effects of collagen tripeptides on skin health compared to nonliposomal forms [Source 1].

What dosage of collagen is recommended?
Clinical trials have used 10 g/day of bioactive collagen peptides to achieve significant improvements in skin health [Source 2].

References

[1] Liposomal Delivery Enhances the Effects of a Collagen Tripeptide-Containing Formulation on Dermal Structure and Optical Skin Parameters: A Randomized, Double-Blind, Placebo-Controlled Trial. Lin YK. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC13039767/

[2] Immune-Modulatory Effects of Bioactive Collagen Peptides Improve Skin Health in Middle-Aged Women. Paula-Vieira RHR. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12936244/